Physician profile
Nelson S Lamarche
NPI 1790752889
$10,996.62
in general payments reported to CMS, 2019-2025
20 companies · $182 in 2025
The $182 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,674 · 2020: $1,134 · 2021: $2,203 · 2022: $282 · 2023: $221 · 2024: $302 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $704.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $6,481.23 | 2019-2020 | |
| Abbott Laboratories | $1,724.47 | 2020-2022 | |
| Medtronic, INC. | $1,326.49 | 2021-2025 | Corevalve Evolut R |
| Boston Scientific Corporation | $347.57 | 2019-2022 | |
| Edwards Lifesciences Corporation | $158.72 | 2019-2021 | |
| Amgen INC. | $153.39 | 2019-2023 | Repatha |
| Astrazeneca Pharmaceuticals LP | $146.94 | 2019-2020 | |
| Amarin Pharma, INC. | $124.99 | 2019 | |
| Abiomed | $82.52 | 2021 | |
| Novartis Pharmaceuticals Corporation | $78.00 | 2020-2022 | |
| Pfizer INC. | $61.47 | 2019-2023 | |
| Shockwave Medical, INC | $57.47 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $53.99 | 2019-2024 | Eliquis |
| Portola Pharmaceuticals, LLC | $41.55 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $39.94 | 2019-2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $30.98 | 2019 | |
| Impulse Dynamics (USA) INC. | $26.09 | 2023 | Optimizer |
| Cardinal Health 200 LLC | $24.83 | 2019 | |
| Daxor Corporation | $20.42 | 2023 | Bva-100 |
| W. L. Gore & Associates, INC. | $15.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nelson Lamarche listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.